Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning.
Jun IshigookaKazuyuki NakagomeTetsuro OhmoriNakao IwataKen InadaJun-Ichi IgaTaro KishiKiyoshi FujitaYuka KikuchiToshiaki ShichijoHideaki TabuseShotatsu KoretsuneHiroshi TeradaHaruko TeradaToshifumi KishimotoYuichiro TsutsumiKazutaka OhiPublished in: BMC psychiatry (2024)
UMIN-Clinical Trials Registry UMIN000007942 (public release date: 14/05/2012).